AIF1 and depressive symptom measurement: At the same time, versus the depression group, the number of Iba1-positive cells in the hippocampus and frontal lobe regions was found to be decreased, while the staining became lighter, and the number of microglia was decreased in the miR-301b inhibitor and SN50 groups.